pubmed-article:16541308 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:16541308 | lifeskim:mentions | umls-concept:C0006141 | lld:lifeskim |
pubmed-article:16541308 | lifeskim:mentions | umls-concept:C0796693 | lld:lifeskim |
pubmed-article:16541308 | lifeskim:mentions | umls-concept:C1521761 | lld:lifeskim |
pubmed-article:16541308 | lifeskim:mentions | umls-concept:C0475264 | lld:lifeskim |
pubmed-article:16541308 | lifeskim:mentions | umls-concept:C0205390 | lld:lifeskim |
pubmed-article:16541308 | lifeskim:mentions | umls-concept:C1521828 | lld:lifeskim |
pubmed-article:16541308 | lifeskim:mentions | umls-concept:C0231175 | lld:lifeskim |
pubmed-article:16541308 | lifeskim:mentions | umls-concept:C1519941 | lld:lifeskim |
pubmed-article:16541308 | lifeskim:mentions | umls-concept:C0376648 | lld:lifeskim |
pubmed-article:16541308 | lifeskim:mentions | umls-concept:C0392760 | lld:lifeskim |
pubmed-article:16541308 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:16541308 | pubmed:dateCreated | 2006-8-23 | lld:pubmed |
pubmed-article:16541308 | pubmed:abstractText | Despite the widespread application of sentinel lymph node biopsy (SLNB) for early stage breast cancer, there is a wide variation in reported test performance characteristics. A major aim of this prospective multicentre validation study was to quantify detection and false-negative rates of SLNB and evaluate factors influencing them. | lld:pubmed |
pubmed-article:16541308 | pubmed:language | eng | lld:pubmed |
pubmed-article:16541308 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16541308 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:16541308 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16541308 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16541308 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16541308 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16541308 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:16541308 | pubmed:month | Sep | lld:pubmed |
pubmed-article:16541308 | pubmed:issn | 0167-6806 | lld:pubmed |
pubmed-article:16541308 | pubmed:author | pubmed-author:NewcombeRober... | lld:pubmed |
pubmed-article:16541308 | pubmed:author | pubmed-author:ManselRobert... | lld:pubmed |
pubmed-article:16541308 | pubmed:author | pubmed-author:GoyalAmitA | lld:pubmed |
pubmed-article:16541308 | pubmed:author | pubmed-author:ALMANAC... | lld:pubmed |
pubmed-article:16541308 | pubmed:author | pubmed-author:ChhabraAlokA | lld:pubmed |
pubmed-article:16541308 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:16541308 | pubmed:volume | 99 | lld:pubmed |
pubmed-article:16541308 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:16541308 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:16541308 | pubmed:pagination | 203-8 | lld:pubmed |
pubmed-article:16541308 | pubmed:meshHeading | pubmed-meshheading:16541308... | lld:pubmed |
pubmed-article:16541308 | pubmed:meshHeading | pubmed-meshheading:16541308... | lld:pubmed |
pubmed-article:16541308 | pubmed:meshHeading | pubmed-meshheading:16541308... | lld:pubmed |
pubmed-article:16541308 | pubmed:meshHeading | pubmed-meshheading:16541308... | lld:pubmed |
pubmed-article:16541308 | pubmed:meshHeading | pubmed-meshheading:16541308... | lld:pubmed |
pubmed-article:16541308 | pubmed:meshHeading | pubmed-meshheading:16541308... | lld:pubmed |
pubmed-article:16541308 | pubmed:meshHeading | pubmed-meshheading:16541308... | lld:pubmed |
pubmed-article:16541308 | pubmed:meshHeading | pubmed-meshheading:16541308... | lld:pubmed |
pubmed-article:16541308 | pubmed:meshHeading | pubmed-meshheading:16541308... | lld:pubmed |
pubmed-article:16541308 | pubmed:meshHeading | pubmed-meshheading:16541308... | lld:pubmed |
pubmed-article:16541308 | pubmed:meshHeading | pubmed-meshheading:16541308... | lld:pubmed |
pubmed-article:16541308 | pubmed:meshHeading | pubmed-meshheading:16541308... | lld:pubmed |
pubmed-article:16541308 | pubmed:meshHeading | pubmed-meshheading:16541308... | lld:pubmed |
pubmed-article:16541308 | pubmed:meshHeading | pubmed-meshheading:16541308... | lld:pubmed |
pubmed-article:16541308 | pubmed:meshHeading | pubmed-meshheading:16541308... | lld:pubmed |
pubmed-article:16541308 | pubmed:meshHeading | pubmed-meshheading:16541308... | lld:pubmed |
pubmed-article:16541308 | pubmed:meshHeading | pubmed-meshheading:16541308... | lld:pubmed |
pubmed-article:16541308 | pubmed:meshHeading | pubmed-meshheading:16541308... | lld:pubmed |
pubmed-article:16541308 | pubmed:meshHeading | pubmed-meshheading:16541308... | lld:pubmed |
pubmed-article:16541308 | pubmed:meshHeading | pubmed-meshheading:16541308... | lld:pubmed |
pubmed-article:16541308 | pubmed:meshHeading | pubmed-meshheading:16541308... | lld:pubmed |
pubmed-article:16541308 | pubmed:meshHeading | pubmed-meshheading:16541308... | lld:pubmed |
pubmed-article:16541308 | pubmed:meshHeading | pubmed-meshheading:16541308... | lld:pubmed |
pubmed-article:16541308 | pubmed:year | 2006 | lld:pubmed |
pubmed-article:16541308 | pubmed:articleTitle | Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer--results of the ALMANAC validation phase. | lld:pubmed |
pubmed-article:16541308 | pubmed:affiliation | Department of Surgery, Wales College of Medicine, Cardiff University, Cardiff, United Kingdom. | lld:pubmed |
pubmed-article:16541308 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:16541308 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
pubmed-article:16541308 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
pubmed-article:16541308 | pubmed:publicationType | Multicenter Study | lld:pubmed |
pubmed-article:16541308 | pubmed:publicationType | Validation Studies | lld:pubmed |